drugset / Trial / NCT05478382

Pregabalin is an Effective Treatment for Acute Postoperative Pain Following Spinal Surgery Without Major Side Effects

NCT05478382

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The objective of this study is to examine the efficacy and side effect of varying dose of pregabalin for the treatment of postoperative pain after spinal surgery.

Timeline

Start
2022-10
Primary completion
2025-12-31
Completion
2025-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Pregabalin Small molecule 25 mg
Subject Pregabalin Small molecule 50 mg
Subject Pregabalin Small molecule 75 mg

Indications

No indication recorded.